- Home
- BXSL vs LNTH Comparison
BXSL vs LNTH Comparison
Compare BXSL & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BXSL | LNTH |
|---|---|---|
| Founded | 2018 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 4.4B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | BXSL | LNTH |
|---|---|---|
| Price | $27.80 | $65.22 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 6 |
| Target Price | $29.38 | ★ $77.33 |
| AVG Volume (30 Days) | ★ 1.5M | 1.1M |
| Earning Date | 11-10-2025 | 11-06-2025 |
| Dividend Yield | ★ 11.06% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.66 | 2.39 |
| Revenue | $1,413,784,000.00 | ★ $1,525,933,000.00 |
| Revenue This Year | $9.05 | $0.01 |
| Revenue Next Year | $0.28 | $1.24 |
| P/E Ratio | ★ $10.48 | $27.23 |
| Revenue Growth | ★ 10.58 | 1.95 |
| 52 Week Low | $24.85 | $47.25 |
| 52 Week High | $34.64 | $111.29 |
Technical Indicators
Market Signals| Indicator | BXSL | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 55.76 | 66.32 |
| Support Level | $28.03 | $60.15 |
| Resistance Level | $28.59 | $67.40 |
| Average True Range (ATR) | 0.41 | 2.04 |
| MACD | -0.03 | 0.52 |
| Stochastic Oscillator | 43.57 | 77.40 |
Price Performance
Historical ComparisonAbout BXSL Blackstone Secured Lending Fund of Beneficial Interest
Blackstone Secured Lending Fund is a non-diversified, closed-end management investment company. The investment objectives of the company are to generate current income and, to a lesser extent, long-term capital appreciation. The company seeks to achieve its investment objectives by investing in originated loans and other securities, including syndicated loans of private U.S. companies, typically in the form of first lien senior secured and unitranche loans, unsecured and subordinated loans, and other securities.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.